
IPHA
USDInnate Pharma S.A. ADS
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$1.880
High
$1.880
Low
$1.840
Volume
0.00M
Company Fundamentals
Market Cap
172.7M
Industry
Biotechnology
Country
France
Trading Stats
Avg Volume
0.02M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates
Regulatory News: Innate Pharma SA (PARIS:IPH, NASDAQ:IPHA) ("Innate" or the "Company") today announced that the Company will hold a conference call on Thursday, November 13, 2025, at 2 p.m. CET / 8 a.m. ET, to give an
HC Wainwright & Co. Upgrades Innate Pharma to Buy, Announces $5 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth upgrades Innate Pharma from Neutral to Buy and announces $5 price target.
BTIG Reiterates Buy on Innate Pharma, Maintains $8 Price Target
BTIG analyst Justin Zelin reiterates Innate Pharma with a Buy and maintains $8 price target.
Related Stocks
CYCCP
Cyclacel Pharmaceuticals Inc. 6% Convertible Preferred Stock
LSBPW
LakeShore Biopharma Co. Ltd Warrants
DXR
Daxor Corporation
APGE
Apogee Therapeutics Inc.
XTNT
Xtant Medical Holdings Inc.
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.